4th Quarter - Report

AMERICAN SOCIETY FOR MICROBIOLOGY for AMERICAN SOCIETY FOR MICROBIOLOGY

Firm
Client
Income
—
Expenses
$50,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
4th Quarter - Report Jan 20, 2023 $50,000 Replaced
4th Quarter - Report (this page) Jan 20, 2023 $50,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

genomic sequencing and surveillance Tracking Pathogens Act (H.R.7152, S. 3534) Antimicrobial resistance (PASTEUR Act, S. 2076, STAAR Act, S. 3291) PREVENT Pandemics Act (S. 3799)

LobbyistCovered position, as disclosed
MARY LEE WATTS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Bills named: S. 2076 (117th), S. 3291 (117th), H.R. 7152 (117th), S. 3799 (117th), S. 3534 (117th)

Budget/Appropriations BUD

Requests for FY 23 funding for NIH, CDC, BARDA, ASPR, USDA, NSF, Department of Energy Office of Science

LobbyistCovered position, as disclosed
AMALIA CORBY-EDWARDS New —
ALLEN SEGAL —
MARY LEE WATTS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Agriculture, Dept of (USDA); Centers For Disease Control & Prevention (CDC)

Science/Technology SCI

Microbiome research coordination S. 1418, Bioeconomy and Research Development Act H.R.4521,Bioeconomy Research and Development Act S. 1260, U.S. Innovation and Competition Act H.R. 2225, NSF for the Future Act H.R.3593, S. 3699, Energy Sciences for the Future Act Chips and Science Act of 2022

LobbyistCovered position, as disclosed
AMALIA CORBY-EDWARDS New —
MARY LEE WATTS —

Contacted: Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1260 (117th), S. 1418 (117th), H.R. 4521 (117th), S. 3699 (117th), H.R. 3593 (117th), H.R. 2225 (117th)

Agriculture AGR

funding for research at USDA, NIFA preliminary Farm Bill

LobbyistCovered position, as disclosed
AMALIA CORBY-EDWARDS New —

Contacted: Agriculture, Dept of (USDA); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

gain of function research of concern diagnostic regulation H.R. 2148 VALID Act S. 2209, VALID Act H.R.6000 , Cures 2.0 pandemic preparedness and clinical lab role H.R.5602,BIO preparedness Workforce Act S. 3244, BIO Preparedness Workforce Act S. 610, Protecting Medicare and Farmers from Sequester Cuts Act SALSA Act H.R. 8188, S. 4449

LobbyistCovered position, as disclosed
ALLEN SEGAL —
MARY LEE WATTS —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Office of Science & Technology Policy (OSTP); Natl Institutes of Health (NIH)

Bills named: H.R. 2148 (117th), S. 610 (117th), S. 2209 (117th), S. 4449 (117th), H.R. 8188 (117th), H.R. 5602 (117th), S. 3244 (117th), H.R. 6000 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.